학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 60건 | 목록 1~10
Academic Journal
Freitas R; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal; ICBAS - Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal; i3S - Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal / INEB - Institute for Biomedical Engineering, University of Porto, 4200-135 Porto, Portugal.; Miranda A; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal; ICBAS - Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal; i3S - Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal / INEB - Institute for Biomedical Engineering, University of Porto, 4200-135 Porto, Portugal.; Ferreira D; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal; ICBAS - Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal; i3S - Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal / INEB - Institute for Biomedical Engineering, University of Porto, 4200-135 Porto, Portugal.; Relvas-Santos M; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal; ICBAS - Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal; i3S - Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal / INEB - Institute for Biomedical Engineering, University of Porto, 4200-135 Porto, Portugal; REQUIMTE-LAQV, Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, 4169-007 Porto, Portugal.; Castro F; i3S - Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal / INEB - Institute for Biomedical Engineering, University of Porto, 4200-135 Porto, Portugal.; Ferreira E; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal.; Gaiteiro C; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal.; Soares J; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal; REQUIMTE-LAQV, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal.; Cotton S; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal; ICBAS - Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal.; Gonçalves M; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal; ICBAS - Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal.; Eiras M; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal; REQUIMTE-LAQV, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal.; Santos B; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal; ICBAS - Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal.; Palmeira C; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal; Immunology Department, Portuguese Oncology Institute of Porto (IPO-Porto), 4200-072 Porto, Portugal; Health School of University Fernando Pessoa, 4249-004 Porto, Portugal.; Correia MP; Cancer Biology & Epigenetics Group, Research Center of IPO Porto (CI-IPOP), 4200-072 Porto, Portugal.; Oliveira MJ; ICBAS - Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal; i3S - Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal / INEB - Institute for Biomedical Engineering, University of Porto, 4200-135 Porto, Portugal.; Sarmento B; i3S - Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal / INEB - Institute for Biomedical Engineering, University of Porto, 4200-135 Porto, Portugal; IUCS-CESPU, 4585-116 Gandra, Portugal.; Peixoto A; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal.; Santos LL; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal; ICBAS - Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal; Health School of University Fernando Pessoa, 4249-004 Porto, Portugal; GlycoMatters Biotech, 4500-162 Espinho, Portugal; Department of Surgical Oncology, Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.; Silva AMN; ICBAS - Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal; REQUIMTE-LAQV, Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, 4169-007 Porto, Portugal; GlycoMatters Biotech, 4500-162 Espinho, Portugal.; Ferreira JA; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal; ICBAS - Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal; GlycoMatters Biotech, 4500-162 Espinho, Portugal. Electronic address: jose.a.ferreira@ipoporto.min-saude.pt.
Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4995 (Electronic) Linking ISSN: 01683659 NLM ISO Abbreviation: J Control Release Subsets: MEDLINE
Academic Journal
Santos DAR; Experimental Pathology and Therapeutics Group, Research Center of IPO Porto (CI-IPOP), RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), Porto Comprehensive Cancer Center (Porto.CCC), 4200-072 Porto, Portugal.; School of Health, Polytechnic Institute of Porto, Rua Dr. António Bernardino de Almeida, 400, 4200-072 Porto, Portugal.; Gaiteiro C; Experimental Pathology and Therapeutics Group, Research Center of IPO Porto (CI-IPOP), RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), Porto Comprehensive Cancer Center (Porto.CCC), 4200-072 Porto, Portugal.; Santos M; School of Health, Polytechnic Institute of Porto, Rua Dr. António Bernardino de Almeida, 400, 4200-072 Porto, Portugal.; Centro de Investigação em Saúde e Ambiente (CISA), Escola Superior de Saúde, Instituto Politécnico do Porto, 4200-072 Porto, Portugal.; Molecular Oncology & Viral Pathology, IPO-Porto Research Center (CI-IPO), Portuguese Institute of Oncology, 4200-072 Porto, Portugal.; Santos L; Experimental Pathology and Therapeutics Group, Research Center of IPO Porto (CI-IPOP), RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), Porto Comprehensive Cancer Center (Porto.CCC), 4200-072 Porto, Portugal.; Department of Surgical Oncology, Portuguese Institute of Oncology (IPO-Porto), 4200-072 Porto, Portugal.; Dinis-Ribeiro M; Precancerous Lesions and Early Cancer Management Group, Research Center of IPO Porto (CI-IPOP), Rise@CI-IPOP (Health Research Group), Portuguese Institute of Oncology of Porto (IPO Porto), Porto Comprehensive Cancer Center (Porto.CCC), 4200-072 Porto, Portugal.; Department of Gastroenterology, Portuguese Oncology Institute of Porto, 4200-072 Porto, Portugal.; Lima L; Experimental Pathology and Therapeutics Group, Research Center of IPO Porto (CI-IPOP), RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), Porto Comprehensive Cancer Center (Porto.CCC), 4200-072 Porto, Portugal.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE
Academic Journal
Costa C; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, Rua Dr. António Bernardino de Almeida, Porto, Portugal.; ICBAS, Abel Salazar Biomedical Sciences Institute, University of Porto, Porto, Portugal.; Health Sciences Faculty of University Fernando Pessoa, Porto, Portugal.; Pereira S; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, Rua Dr. António Bernardino de Almeida, Porto, Portugal.; ICBAS, Abel Salazar Biomedical Sciences Institute, University of Porto, Porto, Portugal.; Health Sciences Faculty of University Fernando Pessoa, Porto, Portugal.; Lima L; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, Rua Dr. António Bernardino de Almeida, Porto, Portugal.; Nucleo de Investigação e Informação em Farmácia - Centro de Investigação em Saúde e Ambiente (CISA), School of Allied Health Sciences - Polytechnic Institute of Oporto, Porto, Portugal.; Institute of Pathology and Molecular Immunology of the University of Porto (IPATIMUP), Porto, Portugal.; Peixoto A; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, Rua Dr. António Bernardino de Almeida, Porto, Portugal.; Fernandes E; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, Rua Dr. António Bernardino de Almeida, Porto, Portugal.; Neves D; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, Rua Dr. António Bernardino de Almeida, Porto, Portugal.; Neves M; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, Rua Dr. António Bernardino de Almeida, Porto, Portugal.; Gaiteiro C; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, Rua Dr. António Bernardino de Almeida, Porto, Portugal.; Tavares A; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, Rua Dr. António Bernardino de Almeida, Porto, Portugal.; Department of Pathology, Portuguese Institute of Oncology, Porto, Portugal.; Gil da Costa RM; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, Rua Dr. António Bernardino de Almeida, Porto, Portugal.; Faculty of Engineering, Laboratory for Process, Environment, Biotechnology and Energy Engineering (LEPABE), University of Porto, Porto, Portugal.; Cruz R; Department of Urology, Portuguese Institute of Oncology, Porto, Portugal.; Amaro T; Department of Urology, Hospital Pedro Hispano, Matosinhos, Portugal.; Oliveira PA; Department of Veterinary Sciences, CITAB, University of Trás-os-Montes and Alto Douro, Vila Real, Portugal.; Ferreira JA; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, Rua Dr. António Bernardino de Almeida, Porto, Portugal.; Mass Spectrometry Center of the University of Aveiro, Campus de Santiago, Aveiro, Portugal.; Santos LL; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, Rua Dr. António Bernardino de Almeida, Porto, Portugal.; Health Sciences Faculty of University Fernando Pessoa, Porto, Portugal.; Department of Surgical Oncology, Portuguese Institute of Oncology, Porto, Portugal.
Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Academic Journal
Gaiteiro C; Experimental Pathology and Therapeutics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute (IPO Porto), 4200-072 Porto, Portugal.; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.; Porto Comprehensive Cancer Center (P.ccc), 4200-072 Porto, Portugal.; Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-313 Porto, Portugal.; Center for Applied Medical Research (Centro de Investigación Médica Aplicada, CIMA), University of Navarra, 31008 Pamplona, Navarra, Spain.; Soares J; Experimental Pathology and Therapeutics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute (IPO Porto), 4200-072 Porto, Portugal.; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.; Porto Comprehensive Cancer Center (P.ccc), 4200-072 Porto, Portugal.; Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-313 Porto, Portugal.; REQUIMTE-LAQV, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal.; Relvas-Santos M; Experimental Pathology and Therapeutics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute (IPO Porto), 4200-072 Porto, Portugal.; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.; Porto Comprehensive Cancer Center (P.ccc), 4200-072 Porto, Portugal.; Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-313 Porto, Portugal.; Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal.; Institute for Biomedical Engineering (INEB), University of Porto, 4200-135 Porto, Portugal.; REQUIMTE-LAQV, Department of Chemistry and Biochemistry, Faculty of Sciences of the University of Porto, 4169-007 Porto, Portugal.; Peixoto A; Experimental Pathology and Therapeutics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute (IPO Porto), 4200-072 Porto, Portugal.; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.; Porto Comprehensive Cancer Center (P.ccc), 4200-072 Porto, Portugal.; Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal.; Institute for Biomedical Engineering (INEB), University of Porto, 4200-135 Porto, Portugal.; Ferreira D; Experimental Pathology and Therapeutics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute (IPO Porto), 4200-072 Porto, Portugal.; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.; Porto Comprehensive Cancer Center (P.ccc), 4200-072 Porto, Portugal.; Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-313 Porto, Portugal.; Center for Applied Medical Research (Centro de Investigación Médica Aplicada, CIMA), University of Navarra, 31008 Pamplona, Navarra, Spain.; Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal.; Institute for Biomedical Engineering (INEB), University of Porto, 4200-135 Porto, Portugal.; Paulo P; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.; Porto Comprehensive Cancer Center (P.ccc), 4200-072 Porto, Portugal.; Cancer Genetics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute (IPO Porto), 4200-072 Porto, Portugal.; Brandão A; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.; Porto Comprehensive Cancer Center (P.ccc), 4200-072 Porto, Portugal.; Cancer Genetics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute (IPO Porto), 4200-072 Porto, Portugal.; Fernandes E; Experimental Pathology and Therapeutics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute (IPO Porto), 4200-072 Porto, Portugal.; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.; Porto Comprehensive Cancer Center (P.ccc), 4200-072 Porto, Portugal.; FP-I3ID, University Fernando Pessoa, 4249-004 Porto, Portugal.; Azevedo R; Laboratoire d'Etude du Métabolisme des Médicaments (LEMM), CEA, INRA, Université Paris Saclay, F-91191, Gif-sur-Yvette cedex, France.; Palmeira C; Experimental Pathology and Therapeutics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute (IPO Porto), 4200-072 Porto, Portugal.; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.; Porto Comprehensive Cancer Center (P.ccc), 4200-072 Porto, Portugal.; FP-I3ID, University Fernando Pessoa, 4249-004 Porto, Portugal.; Immunology Department, Portuguese Oncology Institute (IPO Porto), 4200-072 Porto, Portugal.; Freitas R; Experimental Pathology and Therapeutics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute (IPO Porto), 4200-072 Porto, Portugal.; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.; Porto Comprehensive Cancer Center (P.ccc), 4200-072 Porto, Portugal.; Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-313 Porto, Portugal.; Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal.; Institute for Biomedical Engineering (INEB), University of Porto, 4200-135 Porto, Portugal.; Miranda A; Experimental Pathology and Therapeutics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute (IPO Porto), 4200-072 Porto, Portugal.; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.; Porto Comprehensive Cancer Center (P.ccc), 4200-072 Porto, Portugal.; Faculty of Medicine of the University of Porto, 4200-319 Porto, Portugal.; Osório H; Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal.; Faculty of Medicine of the University of Porto, 4200-319 Porto, Portugal.; Ipatimup-Institute of Molecular Pathology and Immunology of the University of Porto, University of Porto, 4200-135 Porto, Portugal.; Prieto J; Center for Applied Medical Research (Centro de Investigación Médica Aplicada, CIMA), University of Navarra, 31008 Pamplona, Navarra, Spain.; Lima L; Experimental Pathology and Therapeutics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute (IPO Porto), 4200-072 Porto, Portugal.; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.; Porto Comprehensive Cancer Center (P.ccc), 4200-072 Porto, Portugal.; Silva AMN; REQUIMTE-LAQV, Department of Chemistry and Biochemistry, Faculty of Sciences of the University of Porto, 4169-007 Porto, Portugal.; GlycoMatters Biotech, 4500-162 Espinho, Portugal.; Santos LL; Experimental Pathology and Therapeutics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute (IPO Porto), 4200-072 Porto, Portugal.; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.; Porto Comprehensive Cancer Center (P.ccc), 4200-072 Porto, Portugal.; Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-313 Porto, Portugal.; FP-I3ID, University Fernando Pessoa, 4249-004 Porto, Portugal.; GlycoMatters Biotech, 4500-162 Espinho, Portugal.; Department of Surgical Oncology, Portuguese Oncology Institute (IPO Porto), 4200-072 Porto, Portugal.; Ferreira JA; Experimental Pathology and Therapeutics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute (IPO Porto), 4200-072 Porto, Portugal.; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.; Porto Comprehensive Cancer Center (P.ccc), 4200-072 Porto, Portugal.; Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-313 Porto, Portugal.; GlycoMatters Biotech, 4500-162 Espinho, Portugal.
Publisher: Ivyspring International Publisher Country of Publication: Australia NLM ID: 101552395 Publication Model: eCollection Cited Medium: Internet ISSN: 1838-7640 (Electronic) Linking ISSN: 18387640 NLM ISO Abbreviation: Theranostics Subsets: MEDLINE
Academic Journal
Moler, Frank W.Silverstein, Faye S.Nadkarni, Vinay M.Meert, Kathleen L.Shah, Samir H.Slomine, BethChristensen, JamesHolubkov, RichardPage, KentDean, J. MichaelAlten, J.Borasino, S.Pruitt, C.Bush, R.Hock, K.Dure, L.Marullo, D.Sanders, R.Prodhan, P.Hefley, G.Dalton, H.Buttram, S.Wai, K.La Bell, A.Bliss, C.Liss, D.Ortiz, A.Downhour, C.Williams, K.Lavoie, M.Bordes-Edgar, V.Theodorou, A.Typpo, K.Wells, C.Deschenes, J.Teodori, J.Viscusi, C.Katsanis, J.Newth, C.Rubin, S.Bart, R.Deakers, T.Ghuman, A.Khemani, R.Markovitz, B.Dicarlo, J.Ross, P.Wang, V.Villa, M.Fajardo, F.Kwok, J.Serrano, J.Valentine, J.Terry, J.Yamakawa, A.Briones, S.Cauley, S.Briseno, A.Young, C.Nyc, M.Rosser, T.Gold, J.Engilman, R.Schwarz, A.Haykawa, J.Patterson, T.Vargas-Shiraishi, O.Galion, A.Armstrong, P.Mathur, M.Oei, G.Barcega, B.Newcombe, J.Pinto, A.Ashwal, S.Michelson, D.Pivonka-Jones, J.Harrison, R.Kelly, R.Madikians, A.Federman, M.Morgan, M.McQuillen, P.Tabbutt, S.Haeusslein, L.Strong, S.Glass, H.Johnson, B.Loomis, B.Gano, D.Hutchison, J.Schwartz, S.Guerguerian, A.Boutis, K.Clark, D.Van Huyse, J.Fusco, K.McBain, K.Kravecevic, A.Toller, L.Gaiteiro, R.Furness, S.Askaland, R.Hahn, C.Sananes, R.Dobyns, E.Rappaport, L.Jewett, E.Wilson, T.Wathen, B.Dix, M.Allen, J.Garling, T.DiDomenico, D.Loyola, D.Bernard, T.Dise-Lewis, J.Stock, A.Battick, K.Fleming, A.Hanson, J.Macogay, M.Martin, K.Burger, K.Pham, N.Walson, K.Sturm, J.Stone, C.Wellons, A.Meisner, S.Weissman, B.Alexander, A.Johnson, A.Goodman, D.Smith, C.Powell, E.Shah, S.Chiambrietti, J.Lutz, C.Vitt, C.Jackson-McCarthy, L.Leannais, N.Wainwright, M.Goldstein, J.Weil, C.Porter, M.Sullivan, J.Orman, K.Owen, E.Hardin, A.Potter, K.Peterson, E.Ruppe, M.Berkenbosch, J.Padmanabhan, P.McDonald, M.Montgomery, V.Calhoun, A.Thomas, M.Michael, A.Schanie, C.Rayborn, L.Kernen, K.Bratton, T.Good, L.Puri, V.Sears, L.Bhalala, U.Summers, J. LeeBembea, M.Shaffner, D.Walker, A.Shackelford, M.Larson, A.Jamrogowicz, J.Kim, J.Felling, R.Slomine, B.Christensen, J. R.Slomine, B. S.DeMatt, E.Talley, M.Rodweller, C.Meert, K.Heidemann, S.Clark, J.Pawluszka, A.Lulic, M.Frey, M.Sivaswamy, L.Horman, S.Chiodo, L.Moler, F.Stanley, R.Cornell, T.Weber, M.Reske, J.Conlin, L.Silverstein, F.Carlson, M.Warschausky, S.Behnke, T.Poszywak, D.Nowak, J.Ortega, H.Milner, D.Zielinski, E.Doucette, A.Overman, A.Leonard, C.Gilles, E.Huszar, P.Troy, M.Alden, J.Pineda, J.Oren, P.Shoykhet, M.Friess, S.Guilliams, K.Jaffe, D.Day, T.Hicks, T.Barganier, L.Fish, E.Toennies, L.Thurst, P.Blankenship, S.Noetzel, M.White, D.Schleien, C.Cappell, J.Schnadower, DavidTalathoti, N.Sidhu, N.Hinton, V.van der Jagt, E.Taillie, E. R.Nazarian, E.Daugherty, L. E.Davis, C. O.Mulbury, J.Kwon, J.Adams, H.Ofori-Amanfo, G.Bordley, W.Wrenn, S.Uhl, T.Milleson, C.Smith, E.Gustafson, K.Asbeck, S.Gallentine, W.Lloyd, E.Hall, M.Khan, N.Frazier, J.Cohen, DanielHaines, J.Carter, K.Bird, L.Hough, S.Lo, W.Yeates, K.Morfing, K.Ginn, M.Wheeler, D.Geis, G.Beckman, E.Banschbach, S.Monaco, M.Hallinan, B.Walz, N.Lidsky, K.Bergant, S.Browning, A.Haky, J.Bass, N.Tangen, R.Thomas, N.Shelly, A.Vallati, J.Carper, P.Spear, D.McMonagle, A.Stokes, J.Watts, H.Trescher, W.Flaherty-Craig, C.Topjian, A.Berg, B.Nadkarni, V.Fitzgerald, J.Meaney, P.Alpern, E.DiLiberto, M.Twelves, C.McGowan, S.Sisko, M.Park, B.Ichord, R.Radcliffe, J.Thomas, N. HattiangadiFriedman, K.Sullivan, A.Fink, E.Hickey, R.Clark, R.Bell, M.Abraham, A.Bell, R.Varma, R.Beers, S.Feldman, H.Walters, J.McIntyre, K.Anand, K.Woodward, C.Hickerson, A.Moore, B.West, A. NicoGrandberry, M.Shah, N.Clanton, N.Berkelhammer, L.King, O.Huling, A.White, L.Koch, J.Okada, P.Miles, D.Raman, L.Green, M.Golson, E.Jones, A.Kelly, D.Plumb, T.Van de Bruinhorst, K.Dowling, M.Stavinoha, P.Hernandez, A.Wu, T.Bauerfeld, C.Rodkey, M.Dibrell, H.Atkinson, S.O'Donnell, L.Eubanks, J.Loftis, L.Castillo, L.Graf, J.Jaimon, N.Kyle, U.Henry, Y.Dean, J. M.Holubkov, R.Browning, B.Gildea, M.Kuhn, R.Register, K.Tattersall, N.Vrem, A.Webster, A.Clark, A.Page, K.Wang, J.Herrera, L.Yearley, J.Enriquez, R.Demarco, D.Virtosu, M.Su, S.Bell, J.Zuspan, S.Burr, J.Simmons, S.McKean, V.Traeden, C.Nitsuma, H.Bennett, K. S.Lane, R.Lilley, J.Bjerregaard, S.Jacobsen, K.Watson, A.Stephen, D.DelaCruz, M.Cooley, K.Kwendakwema, N.Ameel, B.Jensen, G.Metcalf, M.Cole, R.Moore, R.Morita, D.Burr, R.Bennett, T.Henricksen, J.Hirshberg, E.Hubbard, A.Larsen, G.Poss, B.Schober, M.Sweney, J.Zimmerman, J.McGuire, J.Farris, R.Yanay, O.Reid, J.Smith, L.Brogan, T.Hamilton, S.Barker, R.Greeley, C.Greever, M. SadlerGospe, S.Amlie-Lefond, C.Breiger, D.Paolozzi, A.Berger, J.Wessel, D.Sharron, M.Basu, S.Wratney, A.Dean, N.Brown, K.Reardon, J.Tomanio, E.Ramos, F.Tadesse, B.Menicucci, M.Carpenter, J.Swanson, S.Brennan, T.Glass, P.Malek, B.Mintz, M.Meyer, M.Wakeham, M.Hanson, S.Gorelick, MarcChristensen, M.Triscari, D.Horn, B.Murkowski, K.Hecox, K.Brosig, C.THAPCA Trial Investigators
RESUSCITATION; FEB 2019, 135 p88-p97, 10p.
Academic Journal
Peixoto A; Experimental Pathology and Therapeutics Group, Research Center (CI-IPOP), Portuguese Institute of Oncology, 4200-072, Porto, Portugal.; Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-313, Porto, Portugal.; Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135, Porto, Portugal.; Institute for Biomedical Engineering (INEB), University of Porto, 4200-135, Porto, Portugal.; Ferreira D; Experimental Pathology and Therapeutics Group, Research Center (CI-IPOP), Portuguese Institute of Oncology, 4200-072, Porto, Portugal.; Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135, Porto, Portugal.; Institute for Biomedical Engineering (INEB), University of Porto, 4200-135, Porto, Portugal.; Azevedo R; Experimental Pathology and Therapeutics Group, Research Center (CI-IPOP), Portuguese Institute of Oncology, 4200-072, Porto, Portugal.; Freitas R; Experimental Pathology and Therapeutics Group, Research Center (CI-IPOP), Portuguese Institute of Oncology, 4200-072, Porto, Portugal.; Fernandes E; Experimental Pathology and Therapeutics Group, Research Center (CI-IPOP), Portuguese Institute of Oncology, 4200-072, Porto, Portugal.; Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135, Porto, Portugal.; Institute for Biomedical Engineering (INEB), University of Porto, 4200-135, Porto, Portugal.; Relvas-Santos M; Experimental Pathology and Therapeutics Group, Research Center (CI-IPOP), Portuguese Institute of Oncology, 4200-072, Porto, Portugal.; Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-313, Porto, Portugal.; Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135, Porto, Portugal.; Institute for Biomedical Engineering (INEB), University of Porto, 4200-135, Porto, Portugal.; REQUIMTE-LAQV, Department of Chemistry and Biochemistry, Faculty of Sciences of the University of Porto, 4169-007, Porto, Portugal.; Gaiteiro C; Experimental Pathology and Therapeutics Group, Research Center (CI-IPOP), Portuguese Institute of Oncology, 4200-072, Porto, Portugal.; Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-313, Porto, Portugal.; Soares J; Experimental Pathology and Therapeutics Group, Research Center (CI-IPOP), Portuguese Institute of Oncology, 4200-072, Porto, Portugal.; Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-313, Porto, Portugal.; Cotton S; Experimental Pathology and Therapeutics Group, Research Center (CI-IPOP), Portuguese Institute of Oncology, 4200-072, Porto, Portugal.; Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-313, Porto, Portugal.; Teixeira B; Experimental Pathology and Therapeutics Group, Research Center (CI-IPOP), Portuguese Institute of Oncology, 4200-072, Porto, Portugal.; Paulo P; Cancer Genetics Group, Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072, Porto, Portugal.; Lima L; Experimental Pathology and Therapeutics Group, Research Center (CI-IPOP), Portuguese Institute of Oncology, 4200-072, Porto, Portugal.; Palmeira C; Experimental Pathology and Therapeutics Group, Research Center (CI-IPOP), Portuguese Institute of Oncology, 4200-072, Porto, Portugal.; Immunology Department, Portuguese Institute of Oncology of Porto, 4200-072, Porto, Portugal.; Health School of University Fernando Pessoa, 4249-004, Porto, Portugal.; Martins G; Immunology Department, Portuguese Institute of Oncology of Porto, 4200-072, Porto, Portugal.; Oliveira MJ; Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135, Porto, Portugal.; Institute for Biomedical Engineering (INEB), University of Porto, 4200-135, Porto, Portugal.; Silva AMN; REQUIMTE-LAQV, Department of Chemistry and Biochemistry, Faculty of Sciences of the University of Porto, 4169-007, Porto, Portugal.; Santos LL; Experimental Pathology and Therapeutics Group, Research Center (CI-IPOP), Portuguese Institute of Oncology, 4200-072, Porto, Portugal.; Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-313, Porto, Portugal.; Health School of University Fernando Pessoa, 4249-004, Porto, Portugal.; Department of Surgical Oncology, Portuguese Institute of Oncology, 4200-072, Porto, Portugal.; Porto Comprehensive Cancer Center (P.ccc), 4200-072, Porto, Portugal.; Ferreira JA; Experimental Pathology and Therapeutics Group, Research Center (CI-IPOP), Portuguese Institute of Oncology, 4200-072, Porto, Portugal. jose.a.ferreira@ipoporto.min-saude.pt.; Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-313, Porto, Portugal. jose.a.ferreira@ipoporto.min-saude.pt.; Porto Comprehensive Cancer Center (P.ccc), 4200-072, Porto, Portugal. jose.a.ferreira@ipoporto.min-saude.pt.
Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966 (Electronic) Linking ISSN: 03929078 NLM ISO Abbreviation: J Exp Clin Cancer Res Subsets: MEDLINE
Academic Journal
Fernandes E; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, 4200-162 Porto, Portugal.; Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-013 Porto, Portugal.; Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal.; Institute for Biomedical Engineering (INEB), Porto, Portugal, 4200-135 Porto, Portugal.; Digestive Cancer Research Group, 1495-161 Algés, Portugal.; Freitas R; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, 4200-162 Porto, Portugal.; Ferreira D; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, 4200-162 Porto, Portugal.; Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal.; Institute for Biomedical Engineering (INEB), Porto, Portugal, 4200-135 Porto, Portugal.; Digestive Cancer Research Group, 1495-161 Algés, Portugal.; Soares J; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, 4200-162 Porto, Portugal.; Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-013 Porto, Portugal.; REQUIMTE-LAQV, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal.; Azevedo R; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, 4200-162 Porto, Portugal.; Gaiteiro C; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, 4200-162 Porto, Portugal.; Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-013 Porto, Portugal.; Peixoto A; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, 4200-162 Porto, Portugal.; Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-013 Porto, Portugal.; Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal.; Institute for Biomedical Engineering (INEB), Porto, Portugal, 4200-135 Porto, Portugal.; Oliveira S; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, 4200-162 Porto, Portugal.; Cotton S; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, 4200-162 Porto, Portugal.; Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-013 Porto, Portugal.; Relvas-Santos M; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, 4200-162 Porto, Portugal.; Institute for Biomedical Engineering (INEB), Porto, Portugal, 4200-135 Porto, Portugal.; REQUIMTE-LAQV, Department of Chemistry and Biochemistry, Faculty of Sciences of the University of Porto, 4169-007 Porto, Portugal.; Afonso LP; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, 4200-162 Porto, Portugal.; Pathology Department, Portuguese Institute of Oncology of Porto, 4200-162 Porto, Portugal.; Palmeira C; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, 4200-162 Porto, Portugal.; Immunology Department, Portuguese Institute of Oncology of Porto, 4200-162 Porto, Portugal.; Health Science Faculty, University of Fernando Pessoa, 4249-004 Porto, Portugal.; Oliveira MJ; Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal.; Institute for Biomedical Engineering (INEB), Porto, Portugal, 4200-135 Porto, Portugal.; Ferreira R; REQUIMTE-LAQV, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal.; Silva AMN; REQUIMTE-LAQV, Department of Chemistry and Biochemistry, Faculty of Sciences of the University of Porto, 4169-007 Porto, Portugal.; Lara Santos L; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, 4200-162 Porto, Portugal.; Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-013 Porto, Portugal.; Digestive Cancer Research Group, 1495-161 Algés, Portugal.; Health Science Faculty, University of Fernando Pessoa, 4249-004 Porto, Portugal.; Department of Surgical Oncology, Portuguese Institute of Oncology of Porto, 4200-162 Porto, Portugal.; Department, Porto Comprehensive Cancer Centre (P.ccc), 4200-162 Porto, Portugal.; Ferreira JA; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, 4200-162 Porto, Portugal.; Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-013 Porto, Portugal.; Department, Porto Comprehensive Cancer Centre (P.ccc), 4200-162 Porto, Portugal.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Academic Journal
Neves M; Portuguese Institute of Oncology, Porto, Portugal; Institute of Biomedical Sciences Abel Salazar, University of Porto, Portugal; International Iberian Nanotechnology Laboratory (INL), Braga, Portugal.; Azevedo R; Portuguese Institute of Oncology, Porto, Portugal; Institute of Biomedical Sciences Abel Salazar, University of Porto, Portugal.; Lima L; Portuguese Institute of Oncology, Porto, Portugal; Glycobiology in Cancer, Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Portugal; Instituto de Investigação e Inovação em Saúde (I3S), University of Porto, Portugal.; Oliveira MI; International Iberian Nanotechnology Laboratory (INL), Braga, Portugal.; Peixoto A; Portuguese Institute of Oncology, Porto, Portugal; Institute of Biomedical Sciences Abel Salazar, University of Porto, Portugal; Instituto de Investigação e Inovação em Saúde (I3S), University of Porto, Portugal; INEB-Institute for Biomedical Engineering of Porto, Portugal.; Ferreira D; Portuguese Institute of Oncology, Porto, Portugal.; Soares J; Portuguese Institute of Oncology, Porto, Portugal; Institute of Biomedical Sciences Abel Salazar, University of Porto, Portugal.; Fernandes E; Portuguese Institute of Oncology, Porto, Portugal; Institute of Biomedical Sciences Abel Salazar, University of Porto, Portugal; Instituto de Investigação e Inovação em Saúde (I3S), University of Porto, Portugal; INEB-Institute for Biomedical Engineering of Porto, Portugal.; Gaiteiro C; Portuguese Institute of Oncology, Porto, Portugal; Institute of Biomedical Sciences Abel Salazar, University of Porto, Portugal.; Palmeira C; Portuguese Institute of Oncology, Porto, Portugal.; Cotton S; Portuguese Institute of Oncology, Porto, Portugal; Institute of Biomedical Sciences Abel Salazar, University of Porto, Portugal.; Mereiter S; Glycobiology in Cancer, Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Portugal; Instituto de Investigação e Inovação em Saúde (I3S), University of Porto, Portugal.; Campos D; Glycobiology in Cancer, Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Portugal; Instituto de Investigação e Inovação em Saúde (I3S), University of Porto, Portugal.; Afonso LP; Portuguese Institute of Oncology, Porto, Portugal.; Ribeiro R; Instituto de Investigação e Inovação em Saúde (I3S), University of Porto, Portugal; INEB-Institute for Biomedical Engineering of Porto, Portugal.; Fraga A; Hospital Centre- Hospital of Santo António of Porto, Portugal.; Tavares A; Portuguese Institute of Oncology, Porto, Portugal.; Mansinho H; Hemato-Oncology Clinic, Hospital Garcia de Orta, EPE, Almada, Portugal; Gupo de Investigação do Cancro Digestivo-GICD, Portugal.; Monteiro E; Portuguese Institute of Oncology, Porto, Portugal.; Videira PA; Glycoimmunology Group, UCIBIO, Departamento Ciências da Vida, Faculdade de Ciência e Tecnologia, Universidade NOVA de Lisboa, Caparica, Portugal.; Freitas PP; International Iberian Nanotechnology Laboratory (INL), Braga, Portugal; INESC - Microsistemas e Nanotecnologias, Lisboa, Lisbon, Portugal.; Reis CA; Institute of Biomedical Sciences Abel Salazar, University of Porto, Portugal; Glycobiology in Cancer, Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Portugal; Instituto de Investigação e Inovação em Saúde (I3S), University of Porto, Portugal; Faculty of Medicine, University of Porto, Portugal.; Santos LL; Portuguese Institute of Oncology, Porto, Portugal; Institute of Biomedical Sciences Abel Salazar, University of Porto, Portugal; UFP: School of Health Sciences, Fernando Pessoa University of Porto, Portugal; Porto Comprehensive Cancer Center (P.ccc), Porto, Portugal.; Dieguez L; International Iberian Nanotechnology Laboratory (INL), Braga, Portugal.; Ferreira JA; Portuguese Institute of Oncology, Porto, Portugal; Institute of Biomedical Sciences Abel Salazar, University of Porto, Portugal; International Iberian Nanotechnology Laboratory (INL), Braga, Portugal; Glycobiology in Cancer, Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Portugal; Instituto de Investigação e Inovação em Saúde (I3S), University of Porto, Portugal. Electronic address: jose.a.ferreira@ipoporto.min-saude.pt.
Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101465345 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1876-4347 (Electronic) Linking ISSN: 18716784 NLM ISO Abbreviation: N Biotechnol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Gaiteiro, C.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어